Health

First Ever Drug For Early Breast Cancer Treatment Receives Approval In India

AstraZeneca India has received approval from the Drugs Controller General of India (DGCI) to market its drug for breast cancer treatment. Lynparza is the first and only approved medication in the market that targets breast cancer gene mutations in early-stage. As per data published in the World...